HERG/<< IKr >> channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs, such as [[ dofetilide ]], E4031, and MK-499, at submicromolar concentrations.